Key result
Clopidogrel remains debated as a potential aspirin replacement for long-term secondary CAD prevention.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Berry et al. (2026) studied this question. Clopidogrel is debated as a potential replacement for aspirin for long-term secondary prevention of coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: